4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-23-004732
Chief Commercial Officer sold 267,000 shares at $1.11 ($296,370)
From the SEC's structured data for this filing
Trades in this filing
Evanson Jeff · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-20 | Sale : show line 1 in the form | −267,000 | $1.11 | $296,370 | 745,975 | D |
| Open-market sales · 267,000 sh · avg $1.11 · $296,370 | ||||||
Loading xslF345X03/doc4.xml…